mate I don’t get what your on about. It’s a drug class that’s...

mate I don’t get what your on about. It’s a drug class that’s been proven time and time again and failed to get a response at phase 3 multiple times over multiple drugs. We are now prolonging the half life of the drug in hope we get a response after thousands of patients haven’t responded to the medication. It’s simply a trade before phase 3 and hype on the run up and will exit. The day traders will run this shortly on safety that’s a given

110 million market cap and CEO pointing out it’s a billion dollar market cap on phase 2 success which has been already proven multiple times before hence why I am here